Proactive news snapshot: Tower Resources, ECSC Group, Motif Bio, Asiamet Resources …

A glance at some of the day's highlights from the Proactive Investors newswire

Your daily round-up from the world of Proactive

Tower Resources PLC (LON:TRP) has scheduled a spudding a date of late May for its first well on the Thali block in Cameroon. The Topaz Driller rig is available in the last week in May with the location now agreed with Cameroon’s state oil company SNH.

ECSC Group PLC (LON:ECSC), the provider of cybersecurity services, has bagged three managed services contract wins. Two of the contracts are with two household name retailers (with a combined revenue of more than £2.5bn) and the other is with a technology services provider.

Motif Bio PLC (LON:MTFB) (NASDAQ:MTFB) has delivered new data on its lead drug, iclaprim, at the European Congress of Clinical Microbiology and Infectious Diseases, in Amsterdam. The presentation provided a drill-down into the results from the company’s REVIVE Phase III study of people with skin and skin structure infections.

Asiamet Resources Ltd. (LON:ARS) has reported its final assay results from additional infill drilling completed as part of the ongoing bankable feasibility study for the Beruang Kanan Main copper deposit in Central Kalimantan, Indonesia.

Customised electronic components maker discoverIE Group PLC (LON:DSCV) plans to raise £29mln by placing shares at 400p each and has made two bolt-on acquisitions.

BATM Advanced Communications Limited (LON:BVC) has been awarded the first joint contract for its cybersecurity and networking services by a new armed forced customer.

Risk management software provider KRM22 PLC (LON:KRM) has launched Market Abuse Centre online training programmes through its Global Risk Platform. Big Pic in April.

StatPro Group PLC (LON:SOG) has increased its financing facilities to around £49.1mln through an agreement with Wells Fargo Capital Finance.

Internet of Things enabler Telit Communications PLC (LON:TCM) said it returned to cash profit in the second half of 2018.

Autolus Therapeutics PLC (NASDAQ:AUTL), a portfolio company of biotech investor Arix Bioscience PLC (LON:ARIX), has raised more than expected from its recent public offering.

Braveheart Investment Group PLC (LON:BRH) has disposed of its fund management arm Viking. Payment is in stages, with £110,000 upfront and up to £170,500 to follow once a performance fee for an outstanding fund management contract is agreed. Loans of £650,000 payable to Viking by Braveheart have also been forgiven.

Thor Mining PLC (LON:THR) (ASX:THR) has commenced a drilling programme at the Bonya tungsten deposits adjacent to its Molyhil project in the Northern Territory of Australia.

Ariana Resources PLC (LON:AAU) has seen another strong quarter at its Kiziltepe gold mine in Turkey. Production at the mine eased to 7,296 ounces in the three months to January from 7,517oz in the preceding quarter, but this was still 17% ahead of annualised guidance said Ariana. Big Pic in November.

Bould Opportunities PLC (LON:BOU), the cash shell which this week changed its name from Photonstar LED Group, has confirmed it is considering other funding strategies so it can deliver on its new strategy approved at a recent general meeting. It added that any such fundraise, if concluded, may be at a material discount to the current market price.

Union Jack Oil PLC (LON:UJO) has exited the Holmwood project through a deal with UK Oil & Gas PLC (LON:UKOG), selling its 7.5% stake for £112,500. It is a cash deal, although as part of the transaction UJO has committed to investing the entirety of the proceeds into UKOG, subscribing for new shares.

Europa Oil & Gas Holdings PLC (LON:EOG) has also agreed to sell its 20% stake in the Holmwood project to UK Oil & Gas PLC (LON:UKOG) for £300,000, paid in cash.

Tlou Energy Ltd (LON:TLOU) has raised the equivalent of £1.6mln (or AUS$2.9mln) through a share sale in Botswana. Sophisticated investors in Botswana have subscribed for 29mln new Tlou shares at the equivalent price of 5.5p (or 10 Australian cents) – specifically, the investment comes from a long-term existing shareholder as well as a new Botswana based fund manager.

Greatland Gold PLC (LON:GGP) has announced a new 15-hole drilling programme at its Firetower project in Tasmania, Australia. The exploration firm said the drilling would test targets at Firetower and Firetower East that were identified from geophysical imaging conducted by the company last year.

Caledonia Mining Corporation PLC (LON:CMCL)(TSE:CAL) produced 11,948 ounces from the Blanket mine in Zimbabwe during the quarter ended 31 March. The company maintains its 2019 full year production guidance of between 53,000 ounces and 56,000 ounces, and is still on track with progress towards its target of 80,000 ounces by 2022.

W Resources PLC (LON:WRES) has commenced the commissioning of the jig and mill plant at its La Parrilla tungsten project in Spain.

Highlands Natural Resources PLC (LON:HNR) has announced the appointment of an experienced corporate finance adviser, Nick Tulloch as its finance director and company secretary.

Silence Therapeutics PLC (LON:SLN) has appointed industry veteran Giles Campion as head of research and development and as the company’s chief medical officer. He occupied the same roles at Prosensa, which was acquired by Biomarin in 2015 for US$680mln and, in his 20-year career, he also held senior R&D roles at the Swiss giant Novartis. He holds a medical degree and doctorate from Bristol University.

In a later announcement, Silence also said the search for a permanent chairman continues to be ongoing after announcing that interim chair, Dr Andy Richards, had stepped down with immediate effect.

Advanced Oncotherapy PLC (LON:AVO) has announced the appointment of Moataz Karmalawy as its chief commercial officer and president of its US division with immediate effect.  The group pointed out that the appointment is a non-board appointment.

Eden Research PLC (LON:EDEN) said its CFO Alex Abrey has purchased 50,000 ordinary shares in the company at a price of 10.1p each, and its CEO Sean Smith has purchased 126,624 ordinary shares at an average price of 10.25p per each. Following the transactions, the group added, Abrey is interested in 1,152,824 ordinary shares representing 0.56% of the company's issued share capital, while Smith is interested in 433,393 ordinary shares representing 0.21% of the issued share capital.  

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Bould Opportunities named herein, including the promotion by the Company of Bould Opportunities in any Content on the Site, the Company...



Feedback PLC's Tom Oakley gives clear message to NHS as Bleepa secures CE mark

Feedback PLC's (LON:FDBK) Tom Oakley speaks to Proactive London's Andrew Scott after announcing that Bleepa, its flagship imaging-based medical communications platform, has achieved a CE Mark for Europe. Oakley says Bleepa, which allows clinicians to access medical-grade images through...

1 hour, 4 minutes ago

6 min read